309 related articles for article (PubMed ID: 26675349)
1. Evidence for a role of the histone deacetylase SIRT6 in DNA damage response of multiple myeloma cells.
Cea M; Cagnetta A; Adamia S; Acharya C; Tai YT; Fulciniti M; Ohguchi H; Munshi A; Acharya P; Bhasin MK; Zhong L; Carrasco R; Monacelli F; Ballestrero A; Richardson P; Gobbi M; Lemoli RM; Munshi N; Hideshima T; Nencioni A; Chauhan D; Anderson KC
Blood; 2016 Mar; 127(9):1138-50. PubMed ID: 26675349
[TBL] [Abstract][Full Text] [Related]
2. Depletion of SIRT6 enzymatic activity increases acute myeloid leukemia cells' vulnerability to DNA-damaging agents.
Cagnetta A; Soncini D; Orecchioni S; Talarico G; Minetto P; Guolo F; Retali V; Colombo N; Carminati E; Clavio M; Miglino M; Bergamaschi M; Nahimana A; Duchosal M; Todoerti K; Neri A; Passalacqua M; Bruzzone S; Nencioni A; Bertolini F; Gobbi M; Lemoli RM; Cea M
Haematologica; 2018 Jan; 103(1):80-90. PubMed ID: 29025907
[TBL] [Abstract][Full Text] [Related]
3. SIRT6 stabilizes DNA-dependent protein kinase at chromatin for DNA double-strand break repair.
McCord RA; Michishita E; Hong T; Berber E; Boxer LD; Kusumoto R; Guan S; Shi X; Gozani O; Burlingame AL; Bohr VA; Chua KF
Aging (Albany NY); 2009 Jan; 1(1):109-21. PubMed ID: 20157594
[TBL] [Abstract][Full Text] [Related]
4. SIRT6 coordinates with CHD4 to promote chromatin relaxation and DNA repair.
Hou T; Cao Z; Zhang J; Tang M; Tian Y; Li Y; Lu X; Chen Y; Wang H; Wei FZ; Wang L; Yang Y; Zhao Y; Wang Z; Wang H; Zhu WG
Nucleic Acids Res; 2020 Apr; 48(6):2982-3000. PubMed ID: 31970415
[TBL] [Abstract][Full Text] [Related]
5. CK2α/CSNK2A1 Induces Resistance to Doxorubicin through SIRT6-Mediated Activation of the DNA Damage Repair Pathway.
Hussein UK; Ahmed AG; Song Y; Kim KM; Moon YJ; Ahn AR; Park HS; Ahn SJ; Park SH; Kim JR; Jang KY
Cells; 2021 Jul; 10(7):. PubMed ID: 34359939
[TBL] [Abstract][Full Text] [Related]
6. The histone deacetylase SIRT6 suppresses the expression of the RNA-binding protein PCBP2 in glioma.
Chen X; Hao B; Liu Y; Dai D; Han G; Li Y; Wu X; Zhou X; Yue Z; Wang L; Cao Y; Liu J
Biochem Biophys Res Commun; 2014 Mar; 446(1):364-9. PubMed ID: 24607900
[TBL] [Abstract][Full Text] [Related]
7. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin.
Michishita E; McCord RA; Berber E; Kioi M; Padilla-Nash H; Damian M; Cheung P; Kusumoto R; Kawahara TL; Barrett JC; Chang HY; Bohr VA; Ried T; Gozani O; Chua KF
Nature; 2008 Mar; 452(7186):492-6. PubMed ID: 18337721
[TBL] [Abstract][Full Text] [Related]
8. Mammalian SIRT6 Represses Invasive Cancer Cell Phenotypes through ATP Citrate Lyase (ACLY)-Dependent Histone Acetylation.
Zheng W; Tasselli L; Li TM; Chua KF
Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573442
[TBL] [Abstract][Full Text] [Related]
9. Chromatin regulation and genome maintenance by mammalian SIRT6.
Tennen RI; Chua KF
Trends Biochem Sci; 2011 Jan; 36(1):39-46. PubMed ID: 20729089
[TBL] [Abstract][Full Text] [Related]
10. Cyclic AMP signaling reduces sirtuin 6 expression in non-small cell lung cancer cells by promoting ubiquitin-proteasomal degradation via inhibition of the Raf-MEK-ERK (Raf/mitogen-activated extracellular signal-regulated kinase/extracellular signal-regulated kinase) pathway.
Kim EJ; Juhnn YS
J Biol Chem; 2015 Apr; 290(15):9604-13. PubMed ID: 25713071
[TBL] [Abstract][Full Text] [Related]
11. Activation of SIRT6 by DNA hypomethylating agents and clinical consequences on combination therapy in leukemia.
Carraway HE; Malkaram SA; Cen Y; Shatnawi A; Fan J; Ali HEA; Abd Elmageed ZY; Buttolph T; Denvir J; Primerano DA; Fandy TE
Sci Rep; 2020 Jun; 10(1):10325. PubMed ID: 32587297
[TBL] [Abstract][Full Text] [Related]
12. SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis.
Grootaert MOJ; Finigan A; Figg NL; Uryga AK; Bennett MR
Circ Res; 2021 Feb; 128(4):474-491. PubMed ID: 33353368
[TBL] [Abstract][Full Text] [Related]
13. p53-dependent SIRT6 expression protects Aβ42-induced DNA damage.
Jung ES; Choi H; Song H; Hwang YJ; Kim A; Ryu H; Mook-Jung I
Sci Rep; 2016 May; 6():25628. PubMed ID: 27156849
[TBL] [Abstract][Full Text] [Related]
14. Sirt6 deficiency exacerbates podocyte injury and proteinuria through targeting Notch signaling.
Liu M; Liang K; Zhen J; Zhou M; Wang X; Wang Z; Wei X; Zhang Y; Sun Y; Zhou Z; Su H; Zhang C; Li N; Gao C; Peng J; Yi F
Nat Commun; 2017 Sep; 8(1):413. PubMed ID: 28871079
[TBL] [Abstract][Full Text] [Related]
15. SIRT6 protein deacetylase interacts with MYH DNA glycosylase, APE1 endonuclease, and Rad9-Rad1-Hus1 checkpoint clamp.
Hwang BJ; Jin J; Gao Y; Shi G; Madabushi A; Yan A; Guan X; Zalzman M; Nakajima S; Lan L; Lu AL
BMC Mol Biol; 2015 Jun; 16():12. PubMed ID: 26063178
[TBL] [Abstract][Full Text] [Related]
16. FoxO3 transcription factor and Sirt6 deacetylase regulate low density lipoprotein (LDL)-cholesterol homeostasis via control of the proprotein convertase subtilisin/kexin type 9 (Pcsk9) gene expression.
Tao R; Xiong X; DePinho RA; Deng CX; Dong XC
J Biol Chem; 2013 Oct; 288(41):29252-9. PubMed ID: 23974119
[TBL] [Abstract][Full Text] [Related]
17. A Chemical Biology Approach to Reveal Sirt6-targeted Histone H3 Sites in Nucleosomes.
Wang WW; Zeng Y; Wu B; Deiters A; Liu WR
ACS Chem Biol; 2016 Jul; 11(7):1973-81. PubMed ID: 27152839
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of SIRT6 potentiates the anti-tumor effect of doxorubicin through suppression of the DNA damage repair pathway in osteosarcoma.
Zhang Z; Ha SH; Moon YJ; Hussein UK; Song Y; Kim KM; Park SH; Park HS; Park BH; Ahn AR; Lee SA; Ahn SJ; Kim JR; Jang KY
J Exp Clin Cancer Res; 2020 Nov; 39(1):247. PubMed ID: 33198792
[TBL] [Abstract][Full Text] [Related]
19. Histone deacetylase SIRT6 regulates chemosensitivity in liver cancer cells via modulation of FOXO3 activity.
Hu JQ; Deng F; Hu XP; Zhang W; Zeng XC; Tian XF
Oncol Rep; 2018 Dec; 40(6):3635-3644. PubMed ID: 30542728
[TBL] [Abstract][Full Text] [Related]
20. DNA-independent PARP-1 activation by phosphorylated ERK2 increases Elk1 activity: a link to histone acetylation.
Cohen-Armon M; Visochek L; Rozensal D; Kalal A; Geistrikh I; Klein R; Bendetz-Nezer S; Yao Z; Seger R
Mol Cell; 2007 Jan; 25(2):297-308. PubMed ID: 17244536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
